Clinical trial
A Single Arm, Open, Phase I/II Clinical Study of MASCT-I Treatment for Advanced Solid Tumor
NCT02858232 is registered in ClinicalTrials.gov with The First People's Hospital of Lianyungang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Arm, Open, Phase I/II Clinical Study of MASCT-I Treatment for Advanced Solid Tumor
- Lead sponsor
- The First People's Hospital of Lianyungang
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- August 31, 2016
- Completion date
- December 31, 2018
- Enrollment
- 46 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumors